Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Chester Kao · SciRah

Researcher profile · Semantic Scholar

Chester Kao

Share profile

Chester Kao — researcher profile on SciRah

h-index: 10
Works: 25
Citations: 437

Most-cited papers

Novel therapies are changing treatment paradigms in metastatic prostate cancer
Eric Powers, G. S. Karachaliou, Chester Kao, M. Harrison +4 more
2020Journal of Hematology & Oncology106 citations Open access
Semantic Scholar
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
L. Brown, M. Tucker, Ramy Sedhom, Eric B. Schwartz +13 more
2021Journal for ImmunoTherapy of Cancer99 citations Open access
Semantic Scholar
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
M. Tucker, L. Brown, Yu-Wei Chen, Chester Kao +13 more
2021Biomarker Research37 citations Open access
Semantic Scholar
COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy
Molly M. Daughety, Andrew Morgan, E. Frost, Chester Kao +6 more
2020Thrombosis Research34 citations Open access
Semantic Scholar
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma
S. Alden, Mir Lim, Chester Kao, Daniel H. Shu +8 more
2023Cancer Research Communications33 citations Open access
Semantic Scholar
Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Chester Kao, Eric Powers, Yuan Wu, M. Datto +5 more
2021Clinical Lung Cancer27 citations Open access
Semantic Scholar
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab
Kunal Desai, L. Brown, Wei Wei, M. Tucker +6 more
2021Targeted oncology19 citations Open access
Semantic Scholar
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
L. Brown, Kunal Desai, Wei Wei, E. Kinsey +5 more
2021Journal for ImmunoTherapy of Cancer19 citations Open access
Semantic Scholar
Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
A. Laccetti, B. Garmezy, Lianchun Xiao, M. Economides +17 more
2021Cancer Medicine17 citations Open access
Semantic Scholar
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
L. Brown, Jason Zhu, Kunal Desai, E. Kinsey +18 more
2022Journal for ImmunoTherapy of Cancer14 citations Open access
Semantic Scholar
A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.
Chester Kao, M. McNamara, Chris Alley, N. Spector +4 more
2019Clinical Genitourinary Cancer8 citations
Semantic Scholar
Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types.
L. Brown, Ramy Sedhom, Eric B. Schwartz, Jason Zhu +12 more
20206 citations
Semantic Scholar
Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors.
Chester Kao, Eric Powers, M. Datto, Michelle F. Green +6 more
2020Journal of Clinical Oncology6 citations
Semantic Scholar
An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC).
Chester Kao, D. George, Tian Zhang
2020The Oncologist4 citations Open access
Semantic Scholar
Salvage ipilimumab plus nivolumab in advanced hepatocellular carcinoma after prior anti-PD-(L)1 blockade.
S. Alden, Mir Lim, Chester Kao, Daniel H. Shu +8 more
2023Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Immune checkpoint inhibitor response in tumors with LRP1B variants.
Jason Zhu, M. Tucker, Chester Kao, Matthew K. Labriola +13 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
Incidence, risk factors, and outcomes of immune-related adverse events (irAEs) in a prospective, pan-tumor population.
Aanika Balaji, S. Alden, Howard L. Li, Kabeer Munjal +13 more
2023Journal of Clinical Oncology2 citations
Semantic Scholar
A multicenter retrospective study to evaluate real-world clinical outcomes in patients with metastatic renal cell carcinoma (mRCC) and brain metastasis treated with ipilimumab and nivolumab.
L. Brown, Kunal Desai, Chester Kao, E. Kinsey +16 more
2020Journal of Clinical Oncology2 citations
Semantic Scholar
Association of baseline neutrophil-to-eosinophil ratio (NER) and neutrophil-to-lymphocyte ratio (NLR) with response to combination immunotherapy (IO) with ipilimumab plus nivolumab (ipi/nivo) in patients with metastatic renal cell carcinoma (mRCC).
M. Tucker, L. Brown, Chester Kao, Nathan Hirshman +13 more
2021Journal of Clinical Oncology1 citations
Semantic Scholar
Nivolumab in combination with dabrafenib and trametinib use in advanced cholangiocarcinoma with a BRAF V600E mutation and severe hepatic dysfunction: A case report and review of the literature
Aanika Balaji, Kayla Garzio, K. Oshima, Rachel Klein +2 more
2023Journal of Case Reports and Images in Oncology0 citations Open access
Semantic Scholar
Clonal hematopoiesis association with cardiac function and mortality in patients with solid tumors.
J. Regan, Michelle F. Green, Chester Kao, Eric Powers +5 more
20210 citations
Semantic Scholar
COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy
Molly M. Daughety, T. Ortel, E. Frost, Andrew Morgan +4 more
2020Blood0 citations Open access
Semantic Scholar
Combination therapy with nivolumab and tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
B. Garmezy, Tian Zhang, A. Laccetti, M. Economides +14 more
20200 citations
Semantic Scholar
Multicenter retrospective analysis of patients with metastatic renal cell carcinoma (mRCC) and bone metastases treated with ipilimumab and nivolumab.
Kunal Desai, L. Brown, Wei Wei, Kimberly D. Allman +16 more
2020Journal of Clinical Oncology0 citations
Semantic Scholar
Presentation Judging for the Following Awards 5 : 45 PM ORAL PRESENTATIONS
G. Ajmani, Hunter Eason, Danielle LoRe, Darin T Rosen +44 more
20180 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Tian Zhang×17
Invite
Tian Zhang — researcher profile on SciRah
D. George×14
Invite
D. George — researcher profile on SciRah
M. Harrison×11
Invite
M. Harrison — researcher profile on SciRah
A. Armstrong×11
Invite
A. Armstrong — researcher profile on SciRah

×11

Invite

L. Brown — researcher profile on SciRah

Invite

E. Kinsey — researcher profile on SciRah

Invite

M. Tucker — researcher profile on SciRah

Rajan T. Gupta×6

Invite

Rajan T. Gupta — researcher profile on SciRah

Invite

B. Rini — researcher profile on SciRah

Invite

Jason Zhu — researcher profile on SciRah

Invite

Kunal Desai — researcher profile on SciRah

Invite

M. Ornstein — researcher profile on SciRah